Kwality Pharmaceuticals Board Meeting on May 19

Kwality Pharmaceuticals intimated BSE of its board meeting on May 19, 2026 to approve audited financial results for Q4 and FY ended March 31, 2026.
The company's trading window for insiders remains closed until 48 hours after the financial results are made public on May 19, 2026.
The disclosure is made pursuant to SEBI Listing Regulations Regulation 29 regarding board meeting intimations.